Linked Life Data

8143103

Source:http://linkedlifedata.com/resource/pubmed/id/8143103

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1994-5-3
pubmed:abstractText
Limited vascular access hinders administration of chemotherapy, blood products and antibiotics in cancer patients. Repeated venous cannulation is often psychologically traumatic to patients. The use of a subcutaneous infusion port allows convenient vascular access. Twenty-two cancer patients had ports implanted for venous access (17 patients) and administration of regional chemotherapy (5 patients). The period of indwelling ranged from 70 to 470 days (median 270 days). Two patients (9%) had wound dehiscence that required port revision. Despite this, the wound did not heal in 1 patient and the port had to be removed. Other complications included venous thrombosis (5%) and subcutaneous haematoma (5%). There was no catheter-related bacteraemia. The subcutaneous infusion port provides a suitable vascular access in cancer patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0941-4355
pubmed:author
pubmed:issnType
Print
pubmed:volume
1
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
108-10
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
1993
pubmed:articleTitle
Implantable subcutaneous infusion ports.
pubmed:affiliation
Department of Medical Oncology, Singapore General Hospital.
pubmed:publicationType
Journal Article